Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study

BackgroundInequalities in cancer research participation are thought to exist with certain groups under-represented in research populations; however, much of the evidence is based on small-scale studies. The aim of this study was to explore data from in-depth interviews with cancer patients and a large national survey to investigate variation in who is asked to participate in research and who takes part.MethodsFactors associated with research discussion and participation were explored in National Cancer Patient Experience Survey data using multivariate logistic regression and during in-depth interviews with 25 breast cancer patients.ResultsSurvey data were available for 66,953 cancer patients; 30.4 % reported having discussions about, and 18.9 % took part in, research. Barriers to participation at staff, patient and trust level were evident; for example, staff were less likely to discuss research with older patients, Asian and black patients were less likely to take part and patients treated at specialist or teaching trusts had higher levels of discussion and participation. Interviews showed that patients’ willingness to participate changed over time and was not synonymous with participation as some were ineligible.ConclusionSome patient groups were less likely to have discussions about or participate in research. Analysis of this variation vis-à-vis the composition of the patient population may be useful to ensure that there is equity regarding the potential benefits of research participation and that research findings are applicable to target populations in the translational model.

[1]  B. Thiers Generalizability of Cancer Clinical Trial Results: Prognostic Differences between Participants and NonparticipantsElting LS, Cooksley C, Bekele BN, et al (Univ of Texas, Houston) Cancer 106:2452–2458, 2006§ , 2007 .

[2]  Joy H. Lewis,et al.  Participation of patients 65 years of age or older in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  C. McDaid,et al.  Systematic review of barriers, modifiers and benefits involved in participation in cancer clinical trials , 2006 .

[4]  B Nebiyou Bekele,et al.  Generalizability of cancer clinical trial results , 2006, Cancer.

[5]  D. Kashy,et al.  Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. , 2015, European journal of cancer care.

[6]  M Egger,et al.  The causes and effects of socio-demographic exclusions from clinical trials. , 2005, Health technology assessment.

[7]  Harlan M Krumholz,et al.  Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.

[8]  M. Hansson,et al.  Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. , 2015, European journal of cancer care.

[9]  Z. Hall Cancer , 1906, The Hospital.

[10]  A. Hart,et al.  Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS , 2002, British Journal of Cancer.

[11]  L. Fallowfield,et al.  Clinicians’ attitudes towards clinical trials of cancer therapy , 2011, British Journal of Cancer.

[12]  Shari Bolen,et al.  Provider roles in the recruitment of underrepresented populations to cancer clinical trials , 2007, Cancer.

[13]  J. Donovan,et al.  Capturing users' experiences of participating in cancer trials. , 2002, European journal of cancer care.

[14]  A. Hart,et al.  The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. , 2005, Breast.

[15]  P M Ellis,et al.  Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Louette R. Johnson Lutjens Research , 2006 .

[17]  J. Crawford,et al.  Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials , 2002, Cancer.

[18]  J. Hardy,et al.  Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives. , 2008, European journal of cancer.

[19]  M. Hussain-Gambles,et al.  Involving South Asian patients in clinical trials. , 2004, Health technology assessment.

[20]  R. Jagsi,et al.  Under‐representation of women in high‐impact published clinical cancer research , 2009, Cancer.

[21]  S. Goodman,et al.  Purpose and Benefits of Early Phase Cancer Trials: What Do Oncologists Say? What Do Patients Hear? , 2008, Journal of empirical research on human research ethics : JERHRE.

[22]  M. Christian,et al.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Prescott,et al.  Factors that limit the quality, number and progress of randomised controlled trials. , 1999, Health technology assessment.

[24]  D. Rubio,et al.  Defining Translational Research: Implications for Training , 2010, Academic medicine : journal of the Association of American Medical Colleges.

[25]  P Wainwright,et al.  Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. , 2004, Health technology assessment.

[26]  S. Moore A need to try everything: patient participation in phase I trials. , 2001, Journal of advanced nursing.

[27]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[28]  A. Gafni,et al.  Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Farewell,et al.  Drivers and barriers to patient participation in RCTs , 2013, British Journal of Cancer.

[30]  E. Cook,et al.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review , 2004, The Lancet.